| Revenue | DKK 2K | +0% |
| EBITDA | DKK 2K | +0% |
| Net profit | DKK 2K | -19% |
| Total assets | DKK 49K | +6% |
| Equity | DKK 45K | +5% |
| Employees | — | — |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -9 | -2 | -2 | -2 | -2 | 0 | 2 | 2 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -9 | -2 | -2 | -2 | -2 | -6 | 2 | 2 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -9 | -2 | -2 | -2 | -2 | -6 | 2 | 2 |
| Net financials | 3 | 3 | 3 | 3 | 3 | 3 | 1 | 1 |
| Profit before tax | -7 | 0 | 0 | 0 | 0 | -3 | 3 | 3 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 1 |
| Net profit | -7 | 0 | 0 | 0 | 0 | -3 | 3 | 2 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 43 | 43 | 43 | 43 | 43 | 43 | 46 | 49 |
| Equity | 43 | 43 | 43 | 43 | 43 | 40 | 43 | 45 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 4 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 4 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EW Management | Management | 2017 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ARKMEDIC ApS | Company | 10.0% | 10.0% | 2017 |
| Individual | 10.0% | 10.0% | 2017 | |
| Individual | 10.0% | 10.0% | 2017 | |
| Individual | 5.0% | 5.0% | 2017 | |
| Individual | 5.0% | 5.0% | 2017 | |
| Individual | 5.0% | 5.0% | 2017 | |
| Individual | 5.0% | 5.0% | 2017 | |
| Individual | 5.0% | 5.0% | 2017 | |
| Individual | 5.0% | 5.0% | 2017 | |
LEGE ARTIS CONSULT ApS | Company | 5.0% | 5.0% | 2017 |
| Person | Role here | Other companies |
|---|---|---|
| Erik Wihlborg | Management | 0 companies |